Progress Made in Reducing Low-Value Care
But Choosing Wisely Canada says more needs to be done
As the limits of Canada’s health care systems are being tested by COVID-19 and its sustainability is worrying Canadians, a new report looking at trends over time finds clinicians, patients, researchers and policymakers are making progress in reducing the provision of low-value care.
The overuse of health care, or low-value care, offers little to no benefit to patients and can even cause harm, including side effects, unnecessary exposure to radiation, a cascade of more testing, stress and anxiety, among other things. For Canada’s health systems, overused tests and treatments can increase wait times for people who need care, take up patients’ and clinicians’ time, and waste limited health resources.
This new joint report from Choosing Wisely Canada and the Canadian Institute for Health Information — a follow-up to their 2017 Unnecessary Care in Canada report — provides updated and expanded information on the overuse of tests and treatments in Canada. The earlier report found up to 30 percent of tests, treatments and procedures performed in Canada were potentially unnecessary.
The Overuse of Tests and Treatments in Canada report examines the overuse of 12 selected tests and treatments by looking at trends and variation in use across the country from 2014/15 to 2019/20. (Data from 2020/21 was not part of the trend analysis because it is not fully understood how COVID-19 changed the provision and use of health services).
Over a five-year period, the overuse of eight out of the 12 tests and treatments decreased by 10 percent or more. This represents a reduction of about 826,000 tests, treatments and procedures that would not have benefited patients, including:
- 698,000 fewer unnecessary prescriptions and other treatments;
- 115,000 fewer low-value X-rays, CT scans, MRIs and preoperative tests; and
- 13,000 fewer unnecessary surgical procedures.
“The results are encouraging, but overuse remains an issue and further reductions in low-value care are both possible and necessary,” said Dr. Wendy Levinson, Chair of Choosing Wisely Canada during a webinar announcing the results of the progress report. To achieve widespread change, she said system-level changes are needed, in addition to continued efforts from front-line clinicians and patients.
“Now more than ever, we really need to accelerate work on reducing overuse on low-value care and free-up limited resources to transfer them to where they are absolutely needed,” she said.
The biggest decreases since the 2017 report was produced were: physical restraints in long-term care (decrease of 47 percent;) knee arthroscopy in adults aged 60 and older (decrease of 46 percent) and potentially inappropriate use of antipsychotics in long-term care — decrease of 26 percent).
This report provides examples of actions that have been taken to reduce the overuse of these 12 tests and treatments. These actions may help explain trends and give clinicians, decision-makers and policy-makers ideas for making further reductions.
The report also gauged the Canadian public’s perception of overuse. In 2022, about one in five (19 percent) Canadians reported a test or treatment they did not feel was necessary for their health was recommended to them. This has declined compared with 25 percent in 2019 and 30 percent in 2017.